Anterior Defect Correction With Mesh Plus Treatment of Stress Incontinence With Transobturator or Transvaginal Approach

Sponsor
University Magna Graecia (Other)
Overall Status
Terminated
CT.gov ID
NCT00743535
Collaborator
(none)
15
1
2

Study Details

Study Description

Brief Summary

The incidence of anterior pelvic defect in women is estimated about 10% and it may be often associated to urinary stress incontinence. To date the correction of anterior defects with the use of graft material inserted with transobturator approach has become of large use. Moreover, given the frequent association of urinary stress incontinence to anterior defect, in most of cases it becomes necessary to perform at the same time an anti-incontinence procedure, i.e. a sub-urethral sling positioning. Based on these considerations the aim of this trial will be to compare two different approach for sub-urethral sling positioning, transobturator and transvaginal tape (TOT and TVT) performed in association to transobturator correction of anterior defect with mesh in terms of efficacy and safety.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transobturatory correction of anterior defect plus TOT
  • Procedure: Transobturatory correction of anterior defect plus TVT
Phase 4

Detailed Description

Women with anterior defect and genuine stress urinary incontinence will be enrolled and randomized in two groups (arm 1 and 2). All patients will be treated with a transobturator correction of anterior defect, in patients of arm 1 will be associated TOT, whereas in patients of arm 2 will be associated TVT.

All patients eligible will undergo baseline assessment consisting of anthropometric, clinical, hormonal, urodynamic, and ultrasonographic evaluations. During the study, the surgical outcomes, the clinical subjective and objective efficacy data, and the adverse experiences will be evaluated in each patient.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh
Study Start Date :
Feb 1, 2008
Actual Primary Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Transobturatory correction of anterior defect plus TOT

Procedure: Transobturatory correction of anterior defect plus TOT
Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage. Small incision sites in the femoral/pelvic fold. Bilateral transobturator insertion of mesh by means of mono-use needle

Active Comparator: 2

Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage. Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.

Procedure: Transobturatory correction of anterior defect plus TVT
Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage. Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.

Outcome Measures

Primary Outcome Measures

  1. Objective/subjective symptoms improvements [12 months]

Secondary Outcome Measures

  1. Intra-operative complication rate [one day]

  2. Postoperative complications rate [12 months]

  3. Failure rate [12 months]

  4. Recurrence rate [12 months]

  5. Quality of life [12 months]

  6. Sexual function [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cystocele

  • Genuine stress urinary incontinence by self report, examination and test

  • Urethral hypermobility

  • Eligible for both surgical procedures

  • Ambulatory

Exclusion Criteria:
  • Pregnancy

  • <12 months post-partum

  • Systemic disease and/or drugs known to affect bladder function

  • Current chemotherapy or radiation therapy

  • Urethral diverticulum, augmentation cytoplasty, or artificial sphincter

  • Recent pelvic surgery

  • Previous pelvic or anti-incontinence surgery

  • History of severe abdominopelvic infections

  • Known extensive abdominopelvic adhesions

  • Detrusor instability and/or intrinsic sphincter dysfunction

  • Other gynaecologic pathologies (eg, fibroids, ovarian cysts)

  • BMI >30

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Pugliese" Hospital Catanzaro Italy 88100

Sponsors and Collaborators

  • University Magna Graecia

Investigators

  • Principal Investigator: Stefano Palomba, MD, Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro
  • Study Chair: Fulvio Zullo, MD, Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stefano Palomba, Associate Professor, University Magna Graecia
ClinicalTrials.gov Identifier:
NCT00743535
Other Study ID Numbers:
  • 03/2008
First Posted:
Aug 29, 2008
Last Update Posted:
Apr 8, 2013
Last Verified:
Apr 1, 2013
Keywords provided by Stefano Palomba, Associate Professor, University Magna Graecia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2013